Erratum: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells (PLoS ONE (2020) 15:11 (e0240020) DOI: 10.1371/journal.pone.0240020)

Septelia Inawati Wanandi, Agus Limanto, Elvira Yunita, Resda Akhra Syahrani, Melva Louisa, Agung Eru Wibowo, Sekar Arumsari

Research output: Contribution to journalComment/debate

Abstract

The images for Fig 5A and 5B are incorrectly switched. The image that appears as Fig 5A should be Fig 5B, and the image that appears as Fig 5B should be Fig 5A. The figure captions appear in the correct order. In Fig 5A and 5B, the signs for statistical significance (** and ***) were missing. Please see the correct figures here. In Fig 7, the word “survivin” in the upper right blue box should appear as “p-survivin”. Please see the correct figure here. (Figure Presented).

Original languageEnglish
Article numbere0247694
JournalPloS one
Volume16
Issue number2 February
DOIs
Publication statusPublished - Feb 2021

Fingerprint Dive into the research topics of 'Erratum: In silico and in vitro studies on the anti-cancer activity of andrographolide targeting survivin in human breast cancer stem cells (PLoS ONE (2020) 15:11 (e0240020) DOI: 10.1371/journal.pone.0240020)'. Together they form a unique fingerprint.

Cite this